Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors

  1. John D. Crispino1,5,
  2. Maya B. Lodish1,
  3. Beth L. Thurberg2,
  4. Silvio H. Litovsky3,
  5. Tucker Collins2,
  6. Jeffery D. Molkentin4, and
  7. Stuart H. Orkin1,6
  1. 1Division of Hematology and Oncology, Children's Hospital and Dana Farber Cancer Center, Department of Pediatrics, and Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA; 2Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA; 3Department of Pathology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; 4University of Cincinnati Children's Hospital, Cincinnati, Ohio 45229, USA.

Abstract

GATA-family transcription factors are critical to the development of diverse tissues. In particular, GATA-4 has been implicated in formation of the vertebrate heart. As the mouse Gata-4knock-out is early embryonic lethal because of a defect in ventral morphogenesis, the in vivo function of this factor in heart development remains unresolved. To search for a requirement for Gata4 in heart development, we created mice harboring a single amino acid replacement in GATA-4 that impairs its physical interaction with its presumptive cardiac cofactor FOG-2. Gata4 ki/ki mice die just after embryonic day (E) 12.5 exhibiting features in common with Fog2 −/− embryos as well as additional semilunar cardiac valve defects and a double-outlet right ventricle. These findings establish an intrinsic requirement for GATA-4 in heart development. We also infer that GATA-4 function is dependent on interaction with FOG-2 and, very likely, an additional FOG protein for distinct aspects of heart formation.

Keywords

Footnotes

  • 5 Present address: Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60637, USA.

  • 6 Corresponding author.

  • E-MAIL orkin{at}rascal.med.harvard.edu; FAX (617) 355-7262.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.875201.

    • Received December 19, 2000.
    • Accepted February 2, 2001.
| Table of Contents

Life Science Alliance